Tazarotene是一种选择性视黄酸受体激动剂他扎罗汀酸的前体药物，适用于斑块状银屑病、寻常痤疮及光老化皮肤损伤的治疗研究。
| 英文别名 (English Synonym) | Tazarotene |
| 中文名称 (Chinese Name) | 他扎罗汀 |
| 靶点 (Target) | RARs |
| 通路 (Pathway) | Others |
| CAS号 (CAS NO.) | 118292-40-3 |
| 分子式 (Formula) | C21H21NO2S |
| 分子量 (Molecular Weight) | 351.46 |
| 纯度 (Purity) | ≥98% |
| 溶解性 (Solubility) | 溶于DMSO |
-25~-15℃保存，有效期3年
[1] Talpur R, Cox K, Duvic M. Efficacy and safety of topical tazarotene: a review. Expert Opin Drug Metab Toxicol. 2009 Feb;5(2):195-210. doi: 10.1517/17425250902721250. PMID: 20213916.[2]Nagpal S, Thacher SM, Patel S, Friant S, Malhotra M, Shafer J, Krasinski G, Asano AT, Teng M, Duvic M, Chandraratna RA. Negative regulation of two hyperproliferative keratinocyte differentiation markers by a retinoic acid receptor-specific retinoid: insight into the mechanism of retinoid action in psoriasis. Cell Growth Differ. 1996 Dec;7(12):1783-91. PMID: 8959347.[3]Tang-Liu DD, Matsumoto RM, Usansky JI. Clinical pharmacokinetics and drug metabolism of tazarotene: a novel topical treatment for acne and psoriasis. Clin Pharmacokinet. 1999 Oct;37(4):273-87. doi: 10.2165/00003088-199937040-00001. PMID: 10554045.
